Advanced search
Publication Cover
Climacteric Volume 23, 2020 - Issue sup1: Vaginal lasers in gynecology: the peer-reviewed Proceedings of the 5th VELA Meeting
Submit an article Journal homepage
1,542
Views
12
CrossRef citations to date
0
Altmetric
Short Reports

Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study

M. Gambacciania Department of Obstetrics and Gynecology, University Hospital, Pisa, Italy; Correspondence[email protected]
,
E. Albertinb Gynecological Clinic Elysium, Albignasego (Padova), Italy;
,
M. G. Torellic Centro Palmer, Reggio Emilia, Italy;
,
G. L. Braccod Ospedale Campo di Marte, Lucca, Italy;
,
A. C. Casagrandee Studio Medico, Novara, Italy;
,
L. Martellaf Centro Medico Radiologico 3P, Noventa di Piave, Italy;
,
G. Baiocchig Department of Obstetrics and Gynecology, University of Perugia, Italy;
,
S. Alfierih Centro Mediprò Bologna, Italy;
,
N. Russoi Centro Medico Demetra, Grottaferrata, Italy;
,
M. Cervignij Clinica Paideia, Rome, Italy
& for the Italian Vaginal Erbium Laser Academy show all
Pages S24-S27 | Received 15 Jan 2020, Accepted 23 Jul 2020, Published online: 30 Oct 2020

References

  • Portman DJ, Gass MLS on behalf of the Vulvovaginal Atrophy Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’ s Sexual Health and The North American Menopause Society. Climacteric 2014;17:557–63
  • Levine K, Williams R, Harmann K. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008;15:661–6
  • Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888–902
  • Baber RJ, Panay N, Fenton A; the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
  • The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2017;24:728–53
  • Vizintin Z, Lukac M, Kazic M, Tettamanti M. Erbium laser in gynecology. Climacteric 2015;18(Suppl 1):4–8
  • Gambacciani M, Torelli MG, Martella L, et al. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric 2015;18(Suppl 1):43–8
  • Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol 2015;67:97–102
  • Gambacciani M, Levancini M. Vaginal Erbium Laser: the second generation thermotherapy for the genitourinary syndrome of menopause (GSM) in breast cancer survivors. A preliminary report of a pilot study. Ital J Gynaecol Obstet 2015;27:N.1
  • Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 2015;18:757–63
  • Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of erbium: YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med 2017;49:160–8
  • Gambacciani M, Levancini M. Vaginal erbium laser as second generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause 2017;24:316–19
  • Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric 2018;21:148–52
  • Rosen RC, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191–208
  • Nappi RE, Albani F, Vaccaro P, et al. Use of the Italian translation of the sexual function index (FSFI) in routine gynecological practice. Gynecol Endocrinol 2008;24:214–19
  • Filocamo MT, Serati M, Li Marzi V, et al. The Female Sexual Function Index (FSFI): linguistic validation of the Italian version. J Sex Med 2014;11:447–53
  • DeRogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008;5:357–64
  • Tadir Y, Gaspar A, Lev-Sagie A, et al. Light and energy-based therapeutics for genitourinary syndrome of menopause: Consensus and controversies. Lasers Surg Med 2017;49:137–59
  • Bradford A. Listening to placebo in clinical trials for female sexual dysfunction. J Sex Med 2013;10:451–9
  • American College of Obstetricians and Gynecologists. The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Committee Opinion No. 659. Obstet Gynecol 2016;127:e93–e96
  • Kingsberg SA, Larkin L, Krychman M, et al. WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history. Menopause 2019;26:124–31
  • FDA Warns Against Use of Energy-Based Devices to Perform Vaginal ‘Rejuvenation’ or Vaginal Cosmetic Procedures: FDA Safety Communication. July 30, 2018
  • Gordon C, Gonzales S, Krychman ML. Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy. Menopause 2019;26:423–7
  • Gambacciani M, Cervigni M, Gaspar A, et al. Safety of vaginal erbium laser: a review of 113,000 patients treated in the past 8 years. Climacteric 2020;23(Suppl):S28–S32

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.